TAK-659 and Paclitaxel in Treating Patients With Advanced Solid Tumors

NCT03756818 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

52

Enrollment

OTHER

Sponsor class

Conditions

Advanced Malignant Solid Neoplasm
Ovarian Carcinoma
Refractory Malignant Solid Neoplasm
Refractory Ovarian Carcinoma

Interventions

DRUG: Mivavotinib
DRUG: Paclitaxel
OTHER: Pharmacokinetic Study

Sponsor

M.D. Anderson Cancer Center

Collaborators

[object Object]